Intranasal administration of human MSC for ischemic brain injury in the mouse: In vitro and in vivo neuroregenerative functions

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Donega, Vanessa ^a   Nijboer, Cora H ^a   Braccioli, Luca ^a   Slaper Cortenbach, Ineke ^a   Kavelaars, Annemieke ^b   Van Bel, Frank ^a   Heijnen, Cobi J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; RNA; GLIAL FIBRILLARY ACIDIC PROTEIN; ORGANIC COMPOUND; PKH 26;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN TISSUE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROGLIA; MOUSE; NERVE REGENERATION; NEURAL STEM CELL; NEWBORN; NONHUMAN; RNA ISOLATION; SCAR FORMATION; SENSORIMOTOR FUNCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL MOTION; CYTOLOGY; GLIA; HYPOXIA-ISCHEMIA, BRAIN; INTRANASAL DRUG ADMINISTRATION; MESENCHYMAL STROMA CELL; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; SENSORIMOTOR CORTEX;

ADMINISTRATION, INTRANASAL; ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; MOTOR ACTIVITY; NERVE REGENERATION; NEURAL STEM CELLS; NEUROGLIA; ORGANIC CHEMICALS; SENSORIMOTOR CORTEX;

EID: 84911376433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112339     Document Type: Article

References (40)

1. Dammann O, Ferriero D, Gressens P (2011) Neonatal encephalopathy or hypoxic ischemic encephalopathy? Appropriate terminology matters. Pediatr Res 70: 1-2.
2. De Haan M, Wyatt JS, Roth S, Vargha-Khadem F, Gadian D, et al. (2006) Brain and cognitive-behavioural development after asphyxia at term birth. Dev Sci 9: 350-358.
3. Ferriero DM (2004) Neonatal brain injury. N Engl J Med 351: 1985-1995.
4. Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE (2008) A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol 199: 587-595.
5. van Handel M, Swaab H, de Vries LS, Jongmans MJ (2007) Long-term cognitive and behavioural consequences of neonatal encephalopathy following perinatal asphyxia: a review. Eur J Pediatr 166: 645-654.
6. Wang CC, Chen CH, Lin WW, Hsieh PCH, Lai PH, et al. (2008) Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. Cardiovasc Res 77: 515-524.
7. Gonzalo-Daganzo R, Regidor C, Martin-Donaire T, Rico MA, Bautista G, et al. (2009) Results of a pilot study on the use of third -party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 11: 278-288.
8. Deans RJ, Moseley AB (2000) Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 28: 875-884.
9. Zhang R, Liu Y, Yan K, Chen L, Chen XR, et al. (2013) Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation 10: 106-118.
10. Salem HK, Thiemermann C (2010) Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells 28: 585-596.
11. Donega V, van Velthoven CT, Nijboer CH, van Bel F, Kas MJ, et al. (2013) Intranasal mesenchymal stem cell treatment for neonatal brain damage: Long-Term cognitive and sensorimotor improvement. PLoS ONE 8: e51253.
12. Borlongan CV, Weiss MD (2011) Baby STEPS: A giant leap for cell therapy in neonatal brain injury. Pediatr Res 70: 3-9.
13. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ (2010) Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effect on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 28: 9603-11.
14. Titomanlio L, Kavelaars A, Dalous J, Mani S, El Ghouzzi V, et al. (2011) Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann Neurol 70: 698-712.
15. van Velthoven CT, van de Looij Y, Kavelaars A, Zijlstra J, van Bel F, et al. (2012) Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice. Ann Neurol 71: 785-96.
16. Velthoven C, Kavelaars A, van Bel F, Heijnen CJ (2011) Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun 25: 1342-1348.
17. Yasuhara T, Hara K, Maki M, Mays RW, Deans RJ, et al. (2008) Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab 28: 1804-1810.
18. Tse WT, Pendlenton JD, Beyer WM, Egalka MC, Guinan EC (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75: 389-397.
19. Toyoma K, Honmou O, Harada K, Suzuki J, Houkin K, et al. (2009) Therapeutic benefits of angiogenetic gene-modified human Mesenchymal stem cells after cerebral ischemia. Exp Neurol 216: 47-55.
20. Liu H, Honmou O, Harada K, Nakamura K, Houkin K, et al. (2006) Neuroprotection by PIGF gene-modified human mesenchymal stem cells after cerebral ischemia. Brain 129: 2734-2745.
21. Yang B, Xi XP, Aronowski J, Savitz SI (2012) Ischemic stroke may activate bone marrow mononuclear cells to enhance recovery after stroke. Stem Cells Dev 21: 3332-3340.
22. Prins HJ, Rozemuller H, Vonk-Griffioen S, Verweij VG, Dhert WJ, et al. (2009) Bone forming capacity of mesenchymal stromal cells when cultured in presence of human platelet lysate as substitute for fetal calf serum. Tissue Eng Part A 15: 3741-3751.
23. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marinin F, et al. (2006) Minimal criteria for defining multipotent Mesenchymal stromal cells. The international Society for Cellular Therapy. Cytotherapy 8: 315-317.
24. Horwitz EM, Le BK, Dominici M, Mueller I, Slaper-Cortenbach I, et al. (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393-395.
25. Van Praag H, Kempermann G, Gage FH (1999) Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci 2: 266-270.
26. Van Velthoven CT, Braccioli L, Willemen HL, Kavelaars A, Heijnen CJ (2014) Therapeutic potential of genetically modified mesenchymal stem cells after neonatal hypoxic-ischemic brain damage. Mol Ther 22: 645-654.
27. Croft A, Przyborski SA (2009) Mesenchymal stem cells expressing neural antigens instruct a neurogenic cell fate on neural stem cells. Exp Neurol 216: 329-341.
28. Kempermann G, Gast D, Kronenberg G, Yamagushi M, Gage FH (2003) Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development 130: 391-399.
29. Hack MA, Sugimori M, Lundberg C, Nakafuku M, Gotz M (2004) Regionalization and fate specification in neurospheres: the role of Olig2 and Pax6. Mol Cell Neurosci 25: 664-678.
30. Hack MA, Saghatelyan A, de Chevigny A, Pfeifer A, Ashery-Padan R, et al. (2005) Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci 8: 865-872.
31. Donega V, Nijboer CH, van Tilborg G, Dijkhuizen RM, Kavelaars A, et al. (2014) Intranasally administered mesencymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury. Exp Neurol 261: 53-64.
32. Lee JA, Kim BI, Jo CH, Choi CW, Kim EK, et al. (2010) Mesenchymal stem cell transplantation for hypoxic-ischemic brain injury in neonatal rat model. Pediatr Res 67: 42-46.
33. Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5: 146-156.
34. Sofroniew MV (2014) Multiple Roles for astrocytes as effectors of cytokines and inflammatory mediators. Neuroscientist 20: 160-72.
35. Wake H, Moorhouse AJ, Miyamoto A, Nabekura J (2013) Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci 36: 209-217.
36. Donega V, van Velthoven CT, Nijboer CH, Kavelaars A, Heijnen CH (2013) The endogenous regenerative capacity of the newborn brain: Boosting neurogenesis with mesenchymal stem cell treatment. JCBFM 33: 625-634.
37. Ziebell JM, Morganti-Kossmann MC (2010) Involvement of pro-and antiinflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7: 22-30.
38. Reglero-Real N, Marcos-Ramiro B, Millan J (2012) Endothelial membrane reorganization during leukocyte extravasation. Cell Mol Life Sci 69: 3079-3099.
39. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, et al. (1993) Astrocyte expression of mRNA encoding cyotkines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7: 592.
40. Ubogu EE, Cossoy MB, Ransohoff RM (2006) The expression and function of chemokines involved in CNS inflammation. Trends in Pharmacol Sci 27: 48-55.